Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. (Record no. 28488340)

MARC details
000 -LEADER
fixed length control field 02475 a2200685 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517221641.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201903s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2468-1253
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S2468-1253(18)30118-3
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bourlière, Marc
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190307
245 00 - TITLE STATEMENT
Title Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The lancet. Gastroenterology & hepatology
Date of publication, distribution, etc. 08 2018
300 ## - PHYSICAL DESCRIPTION
Extent 559-565 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aminoisobutyric Acids
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carbamates
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclopropanes
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Combinations
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genotype
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C, Chronic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heterocyclic Compounds, 4 or More Rings
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lactams, Macrocyclic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leucine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Macrocyclic Compounds
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proline
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinoxalines
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element RNA, Viral
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sofosbuvir
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Failure
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Viral Nonstructural Proteins
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gordon, Stuart C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schiff, Eugene R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tran, Tram T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ravendhran, Natarajan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Landis, Charles S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hyland, Robert H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stamm, Luisa M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhang, Jie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dvory-Sobol, Hadas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Subramanian, G Mani
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brainard, Diana M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McHutchison, John G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Serfaty, Lawrence
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thompson, Alex J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sepe, Thomas E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Curry, Michael P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reddy, K Rajender
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Manns, Michael P
773 0# - HOST ITEM ENTRY
Title The lancet. Gastroenterology & hepatology
Related parts vol. 3
-- no. 8
-- p. 559-565
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S2468-1253(18)30118-3">https://doi.org/10.1016/S2468-1253(18)30118-3</a>
Public note Available from publisher's website

No items available.